The Immunopharmacology Unit has the following objectives:
- to activate a sharing network in the "immunology" scientific field;
- to offer a service of analysis and technological support aimed at analyzing the relevant immunological aspects of research projects.
With a view to constantly increasing the quality of service, due attention will be paid to the evolution of flow cytometry and reagent technologies, as well as to new experimental approaches.
Analysis of immune response involvement in different research projects
Many groups, belonging to the Departments of Oncology, Biochemistry and Neuroscience, have already expressed the need to deepen the relevance of the immune response in their areas and research projects. We therefore intend to support these groups with collegial discussions in order to critically analyze the actions already undertaken and, possibly, propose more suitable experimental designs. This activity will also be implemented with ad hoc seminars, sharing of scientific literature and, where required, integration of scientific parts and experimental activities in projects intended for funding requests.
Use of multiparametric flow cytometric methodologies for immune populations analysis
The service offered will be the "continuation and expansion" of what is already in place at the Institute and will offer, to the best of our knowledge, updated experimental approaches that provide for the optimization of multiparametric flow cytometric analyzes, for the determination of the frequencies of immune populations and their functional status; the purification of the same for any omics analysis (genomic, proteomic, metabolomic, lipidomic) and for functional characterizations. A training course will also be periodically organized for those who will express the desire to acquire the basic knowledge for flow cytometric analysis. For the possible use of the analyzer and / or sorter, the new authorized users will be supported by expert staff who will make their skills available for the analysis.
International Consensus on Cardiopulmonary Resuscitation.